Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1857 - 1864 of 11617 results
ESG Fund Rules Reignite Debate on SEC’s Remit
August 4, 2022| News
What's New in 5G - August 2022
August 3, 2022| Blog| Viewpoint
Abortion Privacy Push Pits Biden Against Criminal Laws in States
August 3, 2022| News
NFTs: A Flash in the Crypto Pan or Virtual Gold? (Part 1)
August 2, 2022| Blog| Viewpoint
PBM Regulatory Roundup (Summer 2022): States Continue PBM Oversight Activities
August 2, 2022| Blog| Viewpoint
"Fowl" Play: DOJ Files Lawsuit and Proposed Consent Decrees with Poultry Processors over Wage Suppression Conspiracy
August 2, 2022| Blog| Viewpoint
Summary of Important Tax Provisions Included in the Recently Announced Inflation Reduction Act of 2022
August 1, 2022| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.